|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A randomized, placebo controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘 | POLMAN C O' CONNOR P HAVRDOVA E | 2006 | N Engl J Med2006，354，： | 1 |
| 2 | A randomized,placebo-controlled trial of natalizumab for relapsing multiple sclerosis显示文摘 | Polman CH O'Connor PW Havrdova E | | 0，，： | 1 |
| 3 | A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘 | POLMAN CH O'CONNOR PW HAVRDOVA E | 2006 | N Engl J Med2006，354，9： | 1 |
| 4 | A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘 | Polman CH O'Connor PW Havrdova E | 2006 | N Engl J Med2006，354，9： | 1 |
| 5 | A randomized,placebo-controlled trial of natalizumab for relapsing multiple sclerosis显示文摘 | Polman CH O'Connor PW Havrdova E | 2006 | N Engl J Med2006，354，9： | 1 |
| 6 | Therapeutic considerations for disease progression in multiple sclerosis:evidence, experience, and future expectations 显示文摘 | Frohman EM Stuve 0 Havrdova E | 2005 | Arch Neurol2005，62，10： | 1 |
| 7 | Gray matter atro- phy and disability progression in patients with early relapsing-re- mitting multiple sclerosis: a 5-year longitudinal study 显示文摘 | Horakova D Dwyer MG Havrdova E | 2009 | J Neurol Sci2009，282，12： | 1 |
| 8 | A randomized,placebo-controlled trial of natalizumab for relapsing multiple sclerosis显示文摘 | Polman CH O'Connor PW Havrdova E | 2006 | N Engl J Med2006，354，9： | 1 |
| 9 | Infusion-related hypersensitivity reactions during natalizumab treatment显示文摘 | Phillips JT O'Connor PW Havrdova E | 2006 | Neurology2006，67，9： | 1 |
| 10 | A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘 | Polman CH O'Connor PW Havrdova E | 2006 | N Engl J ned2006，354，9： | 1 |
| 11 | Delayed-Release Dimethyl Fumarate and Pregnancy:Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience显示文摘 | Gold R Phillips JT Havrdova E | 2015 | Neurol Ther2015，4，2： | 1 |
| 12 | Effect of natalizumab on clinical and radiological disease activity in muhiple sclerosis:a ret- rospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis ( AFFIRM ) study 显示文摘 | Havrdova E Galetta S Hutchinson M | 2009 | Lancet Neurol2009，8，3： | 1 |
| 13 | Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis:a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM)study显示文摘 | Havrdova E Galetta S Hutchinson M | 2009 | Lancet Neurol2009，8，： | 1 |
| 14 | Relapse and dis ability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, ran domised, placebo controlled FREEDOMS study显示文摘 | Devonshire V Havrdova E Radue EW | 2012 | Lancet Neurol2012，11，5： | 1 |
| 15 | Myelin basic protein in multiple sclerosis and other neurological disorders显示文摘 | Kalistova H Havrdova E Uhrova J | 2003 | J Neurol2003，250，7： | 1 |
| 16 | A randomized,placebo-controlled trial of natalizumab for relapsing multiple sclerosis显示文摘 | Polman CH O'Connor PW Havrdova E | 2006 | N Engl J Med2006，354，： | 1 |
| 17 | A Randomized, placcebo-controlled trial of natalizumab for relapsing multiple sclerosis 显示文摘 | Polman CH O'Connor PW Havrdova E | 2006 | N Engl J Med2006，354，： | 1 |
| 18 | Magnetic resonance imaging (MRI) efficacy of ofatumumab in relapsing- remitting multiple sclerosis (RRMS)-24-week results of a phase II study显示文摘 | Soelberg-Sorensen P Drulovic J Havrdova E | 2010 | Mult Scler2010，16，： | 1 |
| 19 | Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis:a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis(AFFIRM)study显示文摘 | Havrdova E Galetta S Hutchinson M | 2009 | Lancet Neurol2009，8，3： | 1 |
| 20 | Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis:a retrospective analysis of the Natalizumab Safety and Efficacy in Re- lapsing-Remitting Multiple Sclerosis (AFFIRM) study显示文摘 | Havrdova E G01etta S Hutchinson M | 2009 | Lancet Neuro12009，8，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员